Rituximab possible treatment option for patients with primary biliary cirrhosis - Medical Xpress
Rituximab possible treatment option for patients with primary biliary cirrhosisMedical XpressAn open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol.
Rituximab shows promise against primary biliary cirrhosis - News-Medical.net
Rituximab shows promise against primary biliary cirrhosisNews-Medical.